Uncovering the role of oncogenic HER2 variants as drivers of pancreatic cancer.

被引：0
|
作者：
Kanu, Elishama
Sills, Joelle
Shelley, Rebecca
Ginzel, Joshua
Fernandes, Joseph
Agritelley, Ethan
Fletcher, Ash
Borowsky, Alexander D.
Shi, Chanjuan
Cardiff, Robert D.
Nussbaum, Daniel
Allen, Peter J.
Snyder, Joshua
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ Calif Davis, Davis, CA USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [41] Association of HER2 overexpression and prognosis in small primary breast cancer.
    Schneeweiss, A.
    Schumacher, C.
    Gluz, O.
    Zuna, I.
    Eidt, S.
    Marme, F.
    Nitz, U.
    Sohn, C.
    Rom, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] HER2 testing in gastric cancer. Results of ameeting of German experts
    Baretton, G.
    Dietel, M.
    Gaiser, T.
    Kirchner, T.
    Kreipe, H. H.
    Quaas, A.
    Roecken, C.
    Rueschoff, J.
    Tannapfel, A.
    Lordick, F.
    Al-Batran, S.
    Hofheinz, R.
    Lorenzen, S.
    Moehler, M.
    Thuss-Patience, P.
    PATHOLOGE, 2016, 37 (04): : 361 - 366
  • [43] Nomograms for predicting survival in patients with HER2 negative breast cancer.
    Xu, Yiyue
    Zou, Bing
    Fan, Bingjie
    Li, Butuo
    Wang, Linlin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] HER2, estrogen receptor and methylenetetrahydrofolate gene polymorphisms in breast cancer.
    Dalay, N
    Akisik, E
    Deligezer, U
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S139 - S140
  • [45] Prevalence of MET and HER2 biomarkers in stage IV gastric cancer.
    Loberg, Robert D.
    Tang, Rui
    Oliner, Kelly Smith
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Effect of heterogeneity of HER2 expression on brain metastases of breast cancer.
    Hosonaga, Mari
    Arima, Yoshimi
    Sugihara, Eiji
    Kohno, Norio
    Saya, Hideyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] The impact of HER2 positivity on survival in metastatic gastric and GEJ cancer.
    Kumar, Aalok
    Zhou, Chen
    Huntsman, David
    Kollmannsberger, Christian K.
    Gill, Sharlene
    Lim, Howard John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [48] From the molecule to the clinic - inhibiting HER2 to treat breast cancer.
    Eisenhauer, EA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11): : 841 - 842
  • [49] Metabolic landscape and prognostic value of HER2 in advanced gastric cancer.
    Ock, Chan-Young
    Kim, Tae Yong
    Oh, Do-Youn
    Lee, Kyung-Hun
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] HER2 alterations and prognostic implications in all subtypes of breast cancer.
    O'Keefe, Kaitlyn
    Elliott, Andrew
    Livasy, Chad
    Steiner, Meghan
    Kang, Irene
    Hoon, Dave S. B.
    Korn, Wolfgang Michael
    Walker, Phillip
    Radovich, Milan
    Pohlmann, Paula R.
    Swain, Sandra M.
    Tan, Antoinette R.
    Heeke, Arielle Lutterman
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345